Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Think Bioscience has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Think Bioscience's investors include T.A. Springer, National Science Foundation, Janus Henderson Investors, AV8 Ventures, Innovation Endeavors.
Think Bioscience is headquartered in Boulder, United States.
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Think Bioscience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Think Bioscience — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/think-bioscience. Accessed September 14, 2026.
VCBacked. (2026). Think Bioscience — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/think-bioscience
{{cite web |title=Think Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/think-bioscience |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated